Pregnant woman and provider blood pressure
 

Hypertensive Disorders in Pregnancy: Changes in Diagnosis and Management Toward Improving Morbidity and Mortality

Originally presented on June 12, 2014

Presenter: Peter Cherouny, MD
Emeritus Professor of Obstetrics, Gynecology and Reproductive Sciences
University of Vermont College of Medicine

Dr. Cherouny has strong clinical interests in obstetric health care quality improvement and is currently serving as the Chair of the Institute for Healthcare Improvement’s (IHI's) IMPACT Perinatal Improvement Community. He also currently serves as an obstetric content and quality improvement expert for the New York State Perinatal Quality Collaborative, and was the lead author of the IHI white paper "Idealized Design of Perinatal Care".

Additionally, Dr. Cherouny previously served as the Chair of Quality Assurance and Improvement and Credentialing for the Women's Health Care Service of Fletcher Allen Healthcare for 16 years and of the Medical Staff for three years. Other prior research and work in obstetric quality improvement is as Chair of the March of Dimes collaborative "Improving Prenatal Care in Vermont", and as Co-investigator of the MedTeams project.

Target Audience:

Health care providers that care for pregnant and postpartum women, including: Physicians, nurses, emergency response, midwives, hospital staff and administration.

Objectives

After watching this webcast participants will be able to:
  • Describe recent changes in classification and diagnostic criteria of hypertensive disorders in pregnancy (HDP).
  • Identify highlights of current care for HDP, including risk assessment, evaluation and counseling, and medication management.
  • Differentiate best practices for management of hypertensive disorders in pregnancy in different clinical settings (i.e., pre-hospital, outpatient, inpatient, emergency department and postpartum).
  • Explain how to achieve continuous quality improvement across the care spectrum.


To Obtain Continuing Education Credits:

Each participant interested in CE credits must complete an evaluation and post-test, which is available above under "Evaluation, Post-test & CE Credits". A score of 80% and above on the post-test will generate a certificate indicating the requested credits.


The planners, moderator, and presenters do not have any financial arrangements or affiliations with any commercial entities whose products, research or services may be discussed in this activity.

No commercial funding has been accepted for this activity.


Continuing Medical Education Credits

The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.

The School of Public Health, University at Albany designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Medical Education Credits are offered until June 30, 2017.


Continuing Nurse Education Contact Hours

The University at Albany School of Public Health is an Approved Provider of continuing nurse education by the Northeast Multi-State Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This offering is approved for 1.5 nursing contact hour(s).

Nursing Contact Hours are offered until June 30, 2017.


Certified Health Education Specialist Contact Hours

Sponsored by the School of Public Health, University and Albany, SUNY, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.5 total Category I contact education contact hours. Maximum advanced-level continuing education contact hours available are 0.

Continuing Education Contact Hours are offered until June 30, 2017.